Evidence map›Paper›PMID 29398871›Full record

Trial reportWorld journal of gastroenterology2018

Application value of enhanced recovery after surgery for total laparoscopic uncut Roux-en-Y gastrojejunostomy after distal gastrectomy.

Yi-Feng Zang, Feng-Zhou Li, Zhi-Peng Ji, Yin-Lu Ding

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yi-Feng ZangDepartment of General Surgery, The Second Hospital of Shandong University, Jinan 250033, Shandong Province, China.
Feng-Zhou LiDepartment of General Surgery, The Second Hospital of Shandong University, Jinan 250033, Shandong Province, China.
Zhi-Peng JiDepartment of General Surgery, The Second Hospital of Shandong University, Jinan 250033, Shandong Province, China.
Yin-Lu DingDepartment of General Surgery, The Second Hospital of Shandong University, Jinan 250033, Shandong Province, China. dingyinlu123@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the safety and feasibility of enhanced recovery after surgery (ERAS) for total laparoscopic uncut Roux-en-Y gastrojejunostomy after distal gastrectomy.

methodsThe clinical data of 42 patients who were divided into an ERAS group (

resultsThe operative time, volume of intraoperative blood loss, and number of patients with conversion to open surgery were not significantly different between the two groups. Postoperative clinical indexes, including the time to initial anal exhaust, time to initial liquid diet intake, time to out-of-bed activity, and duration of hospital stay of patients without complications, were significantly different between the two groups (

conclusionThe perioperative ERAS program for total laparoscopic uncut Roux-en-Y gastrojejunostomy after distal gastrectomy is safe and effective and should be popularized. Additionally, this program can also reduce the duration of hospital stay and improve the degree of comfort and satisfaction of patients.

Indexed as

AgedBlood Loss, SurgicalConversion to Open SurgeryC-Reactive ProteinFeasibility StudiesFemaleGastrectomyGastric BypassHumansInterleukin-6LaparoscopyLength of StayLeukocyte CountMaleMiddle AgedOperative TimeC-Reactive ProteinIL6 protein, humanInterleukin-6Distal gastrectomyEnhanced recovery after surgeryPerioperative periodUncut Roux-en-Y gastrojejunostomy

Identifiers

PMID29398871
PMCPMC5787785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.